A.J. Kazimi is chief executive officer of Cumberland Pharmaceuticals, which is ramping up production of a vital drug needed to treat pneumonia resulting from COVID-19.
A.J. Kazimi is chief executive officer of Cumberland Pharmaceuticals, which is ramping up production of a vital drug needed to treat pneumonia resulting from COVID-19.